Wolf Group Capital Advisors Novo Nordisk A S Transaction History

Wolf Group Capital Advisors

  • $234 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$122.71 - $146.91 $265,667 - $318,060
2,165 New
2,165 $309,000
Q1 2022

Apr 20, 2022
SELL
$93.1 - $112.54 $187,410 - $226,543
-2,013 Closed
0 $0
Q4 2021

Jan 19, 2022
BUY
$95.88 - $117.08 $193,006 - $235,682
2,013 New
2,013 $225,000

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wolf Group Capital Advisors Portfolio

Follow Wolf Group Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email